Expectations About the COVID-19 Vaccines

Clinical Trial Description

General hypothesis: Negative expectations and attitudes towards the vaccine are associated with a higher risk of side effects ;

Study Design

See also
Status	Clinical Trial	Phase
Completed	`NCT03966391` - Effectiveness of CARD for Improving School-Based Immunizations	N/A
Completed	`NCT04530357` - Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine	Phase 1/Phase 2
Terminated	`NCT03966300` - Improving the School Vaccination Experience: What CARDs Are You Going to Play?	N/A
Active, not recruiting	`NCT06286488` - Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza	Phase 4
Recruiting	`NCT05546502` - Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children	Phase 3
Active, not recruiting	`NCT05483725` - Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.
Completed	`NCT03600428` - Safety of LAIV4 in Children With Asthma	Phase 4
Completed	`NCT03400878` - Comparing Morbidity and Mortality Effects of Two Different Strains of BCG	Phase 4
Completed	`NCT05116748` - COVID19 Vaccine in SOT Adult Recipients
Not yet recruiting	`NCT05171946` - Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults	Phase 1
Recruiting	`NCT05128721` - Evaluation of Inactivated Vaccine in Healthy Adults Against Coronavirus Disease of 2019 (COVID-19)	Phase 1
Withdrawn	`NCT04894682` - Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor
Not yet recruiting	`NCT05387252` - Glucoside- and Rutinoside-rich Crude Material for Relieving Side Effects of COVID-19 Vaccines	N/A
Active, not recruiting	`NCT04801667` - Evaluate the Impact, Safety, Tolerability and Immunogenicity of the Coronavac Vaccine in Kidney Transplant Recipients	Phase 4
Not yet recruiting	`NCT05283902` - Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly
Recruiting	`NCT05095844` - National Vaccine Adverse Event Reporting Survey and Etiology
Recruiting	`NCT05315856` - Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms
Recruiting	`NCT05898464` - Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV	Phase 4
Recruiting	`NCT05212792` - Genomics and COVID-19 Vaccine Adverse Events
Recruiting	`NCT05258708` - COVID-19 Vaccine Reactogenicity and Immunogenicity

NCT number	NCT04928911
Study type	Observational
Source	University of Aarhus
Contact
Status	Completed
Phase
Start date	June 11, 2021
Completion date	March 31, 2023

Expectations About the COVID-19 Vaccines

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms